AiCuris Starts Its First Pivotal Clinical Phase 3 Trial with Pritelivir for the Treatment of HSV Infections in Immunocompromised Subjects Based on Efficacy and Safety Data from a Phase 2 Trial
The development program focuses on the treatment of immunocompromised patients whose herpes simplex virus (HSV)…